| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |